Advertisement

Journal of Neuroimmune Pharmacology

, Volume 1, Issue 3, pp 223–236 | Cite as

Blood–brain Barrier: Structural Components and Function Under Physiologic and Pathologic Conditions

  • Yuri Persidsky
  • Servio H. Ramirez
  • James Haorah
  • Georgette D. Kanmogne
Invited Review

Abstract

The blood–brain barrier (BBB) is the specialized system of brain microvascular endothelial cells (BMVEC) that shields the brain from toxic substances in the blood, supplies brain tissues with nutrients, and filters harmful compounds from the brain back to the bloodstream. The close interaction between BMVEC and other components of the neurovascular unit (astrocytes, pericytes, neurons, and basement membrane) ensures proper function of the central nervous system (CNS). Transport across the BBB is strictly limited through both physical (tight junctions) and metabolic barriers (enzymes, diverse transport systems). A functional polarity exists between the luminal and abluminal membrane surfaces of the BMVEC. As a result of restricted permeability, the BBB is a limiting factor for the delivery of therapeutic agents into the CNS. BBB breakdown or alterations in transport systems play an important role in the pathogenesis of many CNS diseases (HIV-1 encephalitis, Alzheimer's disease, ischemia, tumors, multiple sclerosis, and Parkinson's disease). Proinflammatory substances and specific disease-associated proteins often mediate such BBB dysfunction. Despite seemingly diverse underlying causes of BBB dysfunction, common intracellular pathways emerge for the regulation of the BBB structural and functional integrity. Better understanding of tight junction regulation and factors affecting transport systems will allow the development of therapeutics to improve the BBB function in health and disease.

Key words

blood–brain barrier leukocyte migration tight junctions multidrug resistance proteins neurovascular unit 

Notes

Acknowledgements

We thank Ms. Robin Taylor and Ms. Debra Baer for excellent administrative support. The NIH National NeuroAIDS Consortium and the CNND brain bank are acknowledged for brain tissue specimens used in this study. This work was supported in part by research grants by the National Institutes of Health: PO1 NS043985, RO1 AA015913, and RO1 MH65151 (Y.P.).

References

  1. Abbott NJ (2000) Inflammatory mediators and modulation of blood–brain barrier permeability. Cell Mol Neurobiol 20:131–147PubMedGoogle Scholar
  2. Abbott NJ (2002) Astrocyte–endothelial interactions and blood–brain barrier permeability. J Anat 200:629–638PubMedGoogle Scholar
  3. Abbott NJ (2005) Dynamics of CNS barriers: evolution, differentiation, and modulation. Cell Mol Neurobiol 25:5–23PubMedGoogle Scholar
  4. Abbott NJ, Ronnback L, Hansson E (2006) Astrocyte–endothelial interactions at the blood–brain barrier. Nat Rev Neurosci 7:41–53PubMedGoogle Scholar
  5. Adamson P, Etienne S, Couraud PO, Calder V, Greenwood J (1999) Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol 162:2964–2973PubMedGoogle Scholar
  6. Alexander JS, Jackson SA, Chaney E, Kevil CG, Haselton FR (1998) The role of cadherin endocytosis in endothelial barrier regulation: involvement of protein kinase C and actin–cadherin interactions. Inflammation 22:419–433PubMedGoogle Scholar
  7. Allport JR, Muller WA, Luscinskas FW (2000) Monocytes induce reversible focal changes in vascular endothelial cadherin complex during transendothelial migration under flow [In Process Citation]. J Cell Biol 148:203–216PubMedGoogle Scholar
  8. Andras IE, Pu H, Tian J, Deli MA, Nath A, Hennig B, Toborek M (2005) Signaling mechanisms of HIV-1 Tat-induced alterations of claudin-5 expression in brain endothelial cells. J Cereb Blood Flow Metab 25:1159–1170PubMedGoogle Scholar
  9. Andreeva AY, Krause E, Muller EC, Blasig IE, Utepbergenov DI (2001) Protein kinase C regulates the phosphorylation and cellular localization of occludin. J Biol Chem 276:38480–38486PubMedGoogle Scholar
  10. Antonetti DA, Barber AJ, Hollinger LA, Wolpert EB, Gardner TW (1999) Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors. J Biol Chem 274:23463–23467PubMedGoogle Scholar
  11. Antonetti DA, Wolpert EB, DeMaio L, Harhaj NS, Scaduto RC, Jr. (2002) Hydrocortisone decreases retinal endothelial cell water and solute flux coincident with increased content and decreased phosphorylation of occludin. J Neurochem 80:667–677PubMedGoogle Scholar
  12. Aurrand-Lions M, Johnson-Leger C, Imhof BA (2002) Role of interendothelial adhesion molecules in the control of vascular functions. Vasc Pharmacol 39:239–246Google Scholar
  13. Avison MJ, Nath A, Greene-Avison R, Schmitt FA, Greenberg RN, Berger JR (2004) Neuroimaging correlates of HIV-associated BBB compromise. J Neuroimmunol 157:140–146PubMedGoogle Scholar
  14. Balda MS, Gonzalez-Mariscal L, Contreras RG, Macias-Silva M, Torres-Marquez ME, Garcia-Sainz JA, Cereijido M (1991) Assembly and sealing of tight junctions: possible participation of G-proteins, phospholipase C, protein kinase C and calmodulin. J Membr Biol 122:193–202PubMedGoogle Scholar
  15. Balda MS, Gonzalez-Mariscal L, Matter K, Cereijido M, Anderson JM (1993) Assembly of the tight junction: the role of diacylglycerol. J Cell Biol 123:293–302PubMedGoogle Scholar
  16. Banks WA (2005) Blood–brain barrier transport of cytokines: a mechanism for neuropathology. Curr Pharm Des 11:973–984PubMedGoogle Scholar
  17. Banks WA, Lebel CR (2002) Strategies for the delivery of leptin to the CNS. J Drug Target 10:297–308PubMedGoogle Scholar
  18. Barreiro O, Yanez-Mo M, Serrador JM, Montoya MC, Vicente-Manzanares M, Tejedor R, Furthmayr H, Sanchez-Madrid F (2002) Dynamic interaction of VCAM-1 and ICAM-1 with moesin and ezrin in a novel endothelial docking structure for adherent leukocytes. J Cell Biol 157:1233–1245PubMedGoogle Scholar
  19. Ben-Menachem E, Johansson BB, Svensson TH (1982) Increased vulnerability of the blood–brain barrier to acute hypertension following depletion of brain noradrenaline. J Neural Transm 53:159–167PubMedGoogle Scholar
  20. Betanzos A, Huerta M, Lopez-Bayghen E, Azuara E, Amerena J, Gonzalez-Mariscal L (2004) The tight junction protein ZO-2 associates with Jun, Fos and C/EBP transcription factors in epithelial cells. Exp Cell Res 292:51–66PubMedGoogle Scholar
  21. Beyenbach KW (2003) Regulation of tight junction permeability with switch-like speed. Curr Opin Nephrol Hypertens 12:543–550PubMedGoogle Scholar
  22. Blouin E, Halbwachs-Mecarelli L, Rieu P (1999) Redox regulation of β2-integrin CD11b/CD18 activation. Eur J Immunol 29:3419–3431PubMedGoogle Scholar
  23. Bolton S, Anthony D, Perry V (1998) Loss of tight junction proteins occludin and zonula occludens-1 from cerebral vascular endothelium during neurophil induced blood–brain barrier breakdown in vivo. Neuroscience 86:1245–1257PubMedGoogle Scholar
  24. Brown RC, Davis TP (2002) Calcium modulation of adherens and tight junction function: a potential mechanism for blood–brain barrier disruption after stroke. Stroke 33:1706–1711PubMedGoogle Scholar
  25. Burridge K, Wennerberg K (2004) Rho and Rac take center stage. Cell 116:167–179PubMedGoogle Scholar
  26. Carman CV, Jun CD, Salas A, Springer TA (2003) Endothelial cells proactively form microvilli-like membrane projections upon intercellular adhesion molecule 1 engagement of leukocyte LFA-1. J Immunol 171:6135–6144PubMedGoogle Scholar
  27. Chen ML, Pothoulakis C, LaMont JT (2002) Protein kinase C signaling regulates ZO-1 translocation and increased paracellular flux of T84 colonocytes exposed to Clostridium difficile toxin A. J Biol Chem 277:4247–4254PubMedGoogle Scholar
  28. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM (2005) P-glycoprotein deficiency at the blood–brain barrier increases amyloid-β deposition in an Alzheimer disease mouse model. J Clin Invest 115:3285–3290PubMedGoogle Scholar
  29. Cisternino S, Mercier C, Bourasset F, Roux F, Scherrmann JM (2004) Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood–brain barrier. Cancer Res 64:3296–3301PubMedGoogle Scholar
  30. Clarke H, Soler AP, Mullin JM (2000) Protein kinase C activation leads to dephosphorylation of occludin and tight junction permeability increase in LLC-PK1 epithelial cell sheets. J Cell Sci 113(Pt 18):3187–3196PubMedGoogle Scholar
  31. Cohen RM, Andreason PJ, Doudet DJ, Carson RE, Sunderland T (1997a) Opiate receptor avidity and cerebral blood flow in Alzheimer's disease. J Neurol Sci 148:171–180PubMedGoogle Scholar
  32. Cohen Z, Molinatti G, Hamel E (1997b) Astroglial and vascular interactions of noradrenaline terminals in the rat cerebral cortex. J Cereb Blood Flow Metab 17:894–904PubMedGoogle Scholar
  33. Cook-Mills JM (2002) VCAM-1 signals during lymphocyte migration: role of reactive oxygen species. Mol Immunol 39:499–508PubMedGoogle Scholar
  34. Cullere X, Shaw SK, Andersson L, Hirahashi J, Luscinskas FW, Mayadas TN (2005) Regulation of vascular endothelial barrier function by Epac, a cAMP-activated exchange factor for Rap GTPase. Blood 105:1950–1955PubMedGoogle Scholar
  35. Dallasta LM, Pisarov LA, Esplen JE, Werley JV, Moses AV, Nelson JA, Achim CL (1999) Blood–brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am J Pathol 155:1915–1927PubMedGoogle Scholar
  36. Del Maschio A, Zanetti A, Corada M, Rival Y, Ruco L, Lampugnani MG, Dejana E (1996) Polymorphonuclear leukocyte adhesion triggers the disorganization of endothelial cell-to-cell adherens junctions. J Cell Biol 135:497–510PubMedGoogle Scholar
  37. Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, Fruscella P, Adorini L, Martino G, Furlan R, De Simoni MG, Dejana E (1999) Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 190:1351–1356PubMedGoogle Scholar
  38. del Zoppo GJ, Hallenbeck JM (2000) Advances in the vascular pathophysiology of ischemic stroke. Thromb Res 98:73–81PubMedGoogle Scholar
  39. Denker BM, Nigam SK (1998) Molecular structure and assembly of the tight junction. Am J Physiol 274:F1–F9PubMedGoogle Scholar
  40. Doolittle ND, Abrey LE, Bleyer WA, Brem S, Davis TP, Dore-Duffy P, Drewes LR, Hall WA, Hoffman JM, Korfel A, Martuza R, Muldoon LL, Peereboom D, Peterson DR, Rabkin SD, Smith Q, Stevens GH, Neuwelt EA (2005) New frontiers in translational research in neuro-oncology and the blood–brain barrier: report of the tenth annual Blood–Brain Barrier Disruption Consortium Meeting. Clin Cancer Res 11:421–428PubMedGoogle Scholar
  41. Dore-Duffy P, Owen C, Balabanov R, Murphy S, Beaumont T, Rafols JA (2000) Pericyte migration from the vascular wall in response to traumatic brain injury. Microvasc Res 60:55–69PubMedGoogle Scholar
  42. Etienne S, Adamson P, Greenwood J, Strosberg AD, Cazaubon S, Couraud PO (1998) ICAM-1 signaling pathways associated with Rho activation in microvascular brain endothelial cells. J Immunol 161:5755–5761PubMedGoogle Scholar
  43. Etienne-Manneville S, Manneville JB, Adamson P, Wilbourn B, Greenwood J, Couraud PO (2000) ICAM-1-coupled cytoskeletal rearrangements and transendothelial lymphocyte migration involve intracellular calcium signaling in brain endothelial cell lines. J Immunol 165:3375–3383PubMedGoogle Scholar
  44. Fanning AS, Jameson BJ, Jesaitis LA, Anderson JM (1998) The tight junction protein ZO-1 establishes a link between the transmembrane protein occludin and the actin cytoskeleton. J Biol Chem 273:29745–29753PubMedGoogle Scholar
  45. Feldman GJ, Mullin JM, Ryan MP (2005) Occludin: structure, function and regulation. Adv Drug Deliv Rev 57:883–917PubMedGoogle Scholar
  46. Fricker G, Miller DS (2004) Modulation of drug transporters at the blood–brain barrier. Pharmacology 70:169–176PubMedGoogle Scholar
  47. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S, Tsukita S, Tsukita S (1993) Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123:1777–1788PubMedGoogle Scholar
  48. Furuse M, Hata M, Furuse K, Yoshida Y, Haratake A, Sugitani Y, Noda T, Kubo A, Tsukita S (2002) Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156:1099–1111PubMedGoogle Scholar
  49. Gonul E, Duz B, Kahraman S, Kayali H, Kubar A, Timurkaynak E (2002) Early pericyte response to brain hypoxia in cats: an ultrastructural study. Microvasc Res 64:116–119PubMedGoogle Scholar
  50. Gonzalez-Mariscal L, Chavez de Ramirez B, Cereijido M (1985) Tight junction formation in cultured epithelial cells (MDCK). J Membr Biol 86:113–125PubMedGoogle Scholar
  51. Gonzalez-Mariscal L, Betanzos A, Avila-Flores A (2000) MAGUK proteins: structure and role in the tight junction. Semin Cell Dev Biol 11:315–324PubMedGoogle Scholar
  52. Graff CL, Pollack GM (2004) Drug transport at the blood–brain barrier and the choroid plexus. Curr Drug Metab 5:95–108PubMedGoogle Scholar
  53. Grigoriadis N, Grigoriadis S, Polyzoidou E, Milonas I, Karussis D (2006) Neuroinflammation in multiple sclerosis: evidence for autoimmune dysregulation, not simple autoimmune reaction. Clin Neurol Neurosurg 108:241–244PubMedGoogle Scholar
  54. Groothuis DR, Vriesendorp FJ, Kupfer B, Warnke PC, Lapin GD, Kuruvilla A, Vick NA, Mikhael MA, Patlak CS (1991) Quantitative measurements of capillary transport in human brain tumors by computed tomography. Ann Neurol 30:581–588PubMedGoogle Scholar
  55. Guo X, Geng M, Du G (2005) Glucose transporter 1, distribution in the brain and in neural disorders: its relationship with transport of neuroactive drugs through the blood–brain barrier. Biochem Genet 43:175–187PubMedGoogle Scholar
  56. Haorah J, Knipe B, Leibhart J, Ghorpade A, Persidsky Y (2005a) Alcohol-induced oxidative stress in brain endothelial cells causes blood–brain barrier dysfunction. J Leukoc Biol 78:1223–1232PubMedGoogle Scholar
  57. Haorah J, Heilman D, Knipe B, Chrastil J, Leibhart J, Ghorpade A, Miller DW, Persidsky Y (2005b) Ethanol-induced activation of myosin light chain kinase leads to dysfunction of tight junctions and blood–brain barrier compromise. Alcohol Clin Exp Res 29:999–1009PubMedGoogle Scholar
  58. Hawkins BT, Davis TP (2005) The blood–brain barrier/neurovascular unit in health and disease. Pharmacol Rev 57:173–185PubMedGoogle Scholar
  59. Hayashi K, Pu H, Tian J, Andras IE, Lee YW, Hennig B, Toborek M (2005a) HIV-Tat protein induces P-glycoprotein expression in brain microvascular endothelial cells. J Neurochem 93:1231–1241PubMedGoogle Scholar
  60. Hayashi K, Pu H, Andras IE, Eum SY, Yamauchi A, Hennig B, Toborek M (2005b) HIV-TAT protein upregulates expression of multidrug resistance protein 1 in the blood–brain barrier. J Cereb Blood Flow MetabGoogle Scholar
  61. Hirase T, Staddon JM, Saitou M, Ando-Akatsuka Y, Itoh M, Furuse M, Fujimoto K, Tsukita S, Rubin LL (1997) Occludin as a possible determinant of tight junction permeability in endothelial cells. J Cell Sci 110 (Pt 14):1603–1613PubMedGoogle Scholar
  62. Hirase T, Kawashima S, Wong E, Uemada T, Rikitake Y, Tsukita S, Yokoyama M, Staddon J (2001) Regulation of tight junction permeability and occludin phosphorylation byRhoA-p160ROCK-dependent and independent mechanism. J Biol Chem 276:10423–10431PubMedGoogle Scholar
  63. Holash JA, Noden DM, Stewart PA (1993) Re-evaluating the role of astrocytes in blood–brain barrier induction. Dev Dyn 197:14–25PubMedGoogle Scholar
  64. Hopkins AM, Li D, Mrsny RJ, Walsh SV, Nusrat A (2000) Modulation of tight junction function by G protein-coupled events. Adv Drug Deliv Rev 41:329–340PubMedGoogle Scholar
  65. Howarth AG, Hughes MR, Stevenson BR (1992) Detection of the tight junction-associated protein ZO-1 in astrocytes and other nonepithelial cell types. Am J Physiol 262:C461–C469PubMedGoogle Scholar
  66. Huber JD, Egleton RD, Davis TP (2001) Molecular physiology and pathophysiology of tight junctions in the blood–brain barrier. Trends Neurosci 24:719–725PubMedGoogle Scholar
  67. Inoko A, Itoh M, Tamura A, Matsuda M, Furuse M, Tsukita S (2003) Expression and distribution of ZO-3, a tight junction MAGUK protein, in mouse tissues. Genes Cells 8:837–845PubMedGoogle Scholar
  68. Islas S, Vega J, Ponce L, Gonzalez-Mariscal L (2002) Nuclear localization of the tight junction protein ZO-2 in epithelial cells. Exp Cell Res 274:138–148PubMedGoogle Scholar
  69. Itoh M, Morita K, Tsukita S (1999) Characterization of ZO-2 as a MAGUK family member associated with tight as well as adherens junctions with a binding affinity to occludin and α catenin. J Biol Chem 274:5981–5986PubMedGoogle Scholar
  70. Jian Liu K, Rosenberg GA (2005) Matrix metalloproteinases and free radicals in cerebral ischemia. Free Radic Biol Med 39:71–80PubMedGoogle Scholar
  71. Kanmogne GD, Primeaux C, Grammas P (2005) HIV-1 gp120 proteins alter tight junction protein expression and brain endothelial cell permeability: implications for the pathogenesis of HIV-associated dementia. J Neuropathol Exp Neurol 64:498–505PubMedGoogle Scholar
  72. Kanmogne GD, Schall K, Leibhart J, Knipe B, Gendelman HE, Persidsky Y (2006) HIV-1 gp120 compromises blood–brain barrier integrity and enhance monocyte migration across blood–brain barrier: implication for viral neuropathogenesis. J Cereb Blood Flow Metab. (in press)Google Scholar
  73. Khanday FA, Yamamori T, Mattagajasingh I, Zhang Z, Bugayenko A, Naqvi A, Santhanam L, Nabi N, Kasuno K, Day BW, Irani K (2006) Rac1 leads to phosphorylation-dependent increase in stability of the p66shc adaptor protein: role in Rac1-induced oxidative stress. Mol Biol Cell 17:122–129PubMedGoogle Scholar
  74. Klingler C, Kniesel U, Bamforth SD, Wolburg H, Engelhardt B, Risau W (2000) Disruption of epithelial tight junctions is prevented by cyclic nucleotide-dependent protein kinase inhibitors. Histochem Cell Biol 113:349–361PubMedGoogle Scholar
  75. Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH (2005) Blood–brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol 57:176–179PubMedGoogle Scholar
  76. Kubota K, Furuse M, Sasaki H, Sonoda N, Fujita K, Nagafuchi A, Tsukita S (1999) Ca(2+)-independent cell-adhesion activity of claudins, a family of integral membrane proteins localized at tight junctions. Curr Biol 9:1035–1038PubMedGoogle Scholar
  77. Kunsch C, Luchoomun J, Grey JY, Olliff LK, Saint LB, Arrendale RF, Wasserman MA, Saxena U, Medford RM (2004) Selective inhibition of endothelial and monocyte redox-sensitive genes by AGI-1067: a novel antioxidant and anti-inflammatory agent. J Pharmacol Exp Ther 308:820–829PubMedGoogle Scholar
  78. Lai CH, Kuo KH (2005) The critical component to establish in vitro BBB model: pericyte. Brain Res Rev 50:258–265PubMedGoogle Scholar
  79. Lamszus K, Laterra J, Westphal M, Rosen EM (1999) Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 17:517–530PubMedGoogle Scholar
  80. Langford D, Grigorian A, Hurford R, Adame A, Ellis RJ, Hansen L, Masliah E (2004) Altered P-glycoprotein expression in AIDS patients with HIV encephalitis. J Neuropathol Exp Neurol 63:1038–1047PubMedGoogle Scholar
  81. Lassmann H (2004) Recent neuropathological findings in MS—implications for diagnosis and therapy. J Neurol 251(Suppl 4):IV2–IV5PubMedGoogle Scholar
  82. Le Moellic C, Boulkroun S, Gonzalez-Nunez D, Dublineau I, Cluzeaud F, Fay M, Blot-Chabaud M, Farman N (2005) Aldosterone and tight junctions: modulation of claudin-4 phosphorylation in renal collecting duct cells. Am J Physiol Cell Physiol 289:C1513–C1521PubMedGoogle Scholar
  83. Lee G, Bendayan R (2004) Functional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders. Pharm Res 21:1313–1330PubMedGoogle Scholar
  84. Lee EJ, Hung YC, Lee MY (1999) Early alterations in cerebral hemodynamics, brain metabolism, and blood–brain barrier permeability in experimental intracerebral hemorrhage. J Neurosurg 91:1013–1019PubMedCrossRefGoogle Scholar
  85. Lee G, Dallas S, Hong M, Bendayan R (2001) Drug transporters in the central nervous system: brain barriers and brain parenchyma considerations. Pharmacol Rev 53:569–596PubMedGoogle Scholar
  86. Leslie EM, Deeley RG, Cole SP (2005) Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense. Toxicol Appl Pharmacol 204:216–237PubMedGoogle Scholar
  87. Liebner S, Fischmann A, Rascher G, Duffner F, Grote EH, Kalbacher H, Wolburg H (2000) Claudin-1 and claudin-5 expression and tight junction morphology are altered in blood vessels of human glioblastoma multiforme. Acta Neuropathol (Berl) 100:323–331Google Scholar
  88. Loscher W, Potschka H (2005a) Drug resistance in brain diseases and the role of drug efflux transporters. Nat Rev Neurosci 6:591–602PubMedGoogle Scholar
  89. Loscher W, Potschka H (2005b) Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases. Prog Neurobiol 76:22–76PubMedGoogle Scholar
  90. Ma TY, Tran D, Hoa N, Nguyen D, Merryfield M, Tarnawski A (2000) Mechanism of extracellular calcium regulation of intestinal epithelial tight junction permeability: role of cytoskeletal involvement. Microsc Res Tech 51:156–168PubMedGoogle Scholar
  91. Mankowski JL, Queen SE, Kirstein LM, Spelman JP, Laterra J, Simpson IA, Adams RJ, Clements JE, Zink MC (1999) Alterations in blood–brain barrier glucose transport in SIV-infected macaques. J Neurovirology 5:695–702Google Scholar
  92. Mark KS, Davis TP (2002) Cerebral microvascular changes in permeability and tight junctions induced by hypoxia-reoxygenation. Am J Physiol Heart Circ Physiol 282:H1485–H1494PubMedGoogle Scholar
  93. Marroni M, Marchi N, Cucullo L, Abbott NJ, Signorelli K, Janigro D (2003) Vascular and parenchymal mechanisms in multiple drug resistance: a lesson from human epilepsy. Curr Drug Targets 4:297–304PubMedGoogle Scholar
  94. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D, Dejana E (1998) Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142:117–127PubMedGoogle Scholar
  95. Matheny HE, Deem TL, Cook-Mills JM (2000) Lymphocyte migration through monolayers of endothelial cell lines involves VCAM-1 signaling via endothelial cell NADPH oxidase. J Immunol 164:6550–6559PubMedGoogle Scholar
  96. McCarthy KM, Skare IB, Stankewich MC, Furuse M, Tsukita S, Rogers RA, Lynch RD, Schneeberger EE (1996) Occludin is a functional component of the tight junction. J Cell Sci 109(Pt 9):2287–2298PubMedGoogle Scholar
  97. McGeer EG, Klegeris A, McGeer PL (2005) Inflammation, the complement system and the diseases of aging. Neurobiol Aging 26(Suppl 1):94–97PubMedGoogle Scholar
  98. Minagar A, Alexander JS (2003) Blood–brain barrier disruption in multiple sclerosis. Mult Scler 9:540–549PubMedGoogle Scholar
  99. Mitic LL, Anderson JM (1998) Molecular architecture of tight junctions. Annu Rev Physiol 60:121–142PubMedGoogle Scholar
  100. Morita K, Sasaki H, Furuse M, Tsukita S (1999) Endothelial claudin: claudin-5/TMVCF constitutes tight junction strands in endothelial cells. J Cell Biol 147:185–194PubMedGoogle Scholar
  101. Morita K, Sasaki H, Furuse K, Furuse M, Tsukita S, Miyachi Y (2003) Expression of claudin-5 in dermal vascular endothelia. Exp Dermatol 12:289–295PubMedGoogle Scholar
  102. Muller WA (2003) Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 24:327–334PubMedGoogle Scholar
  103. Nitta T, Hata M, Gotoh S, Seo Y, Sasaki H, Hashimoto N, Furuse M, Tsukita S (2003) Size-selective loosening of the blood–brain barrier in claudin-5-deficient mice. J Cell Biol 161:653–660PubMedGoogle Scholar
  104. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, McComb RD, Swindells S, Soderland C, Gendelman HE (1996) Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156:1284–1295PubMedGoogle Scholar
  105. Nunbhakdi-Craig V, Machleidt T, Ogris E, Bellotto D, White CL, 3rd, Sontag E (2002) Protein phosphatase 2A associates with and regulates atypical PKC and the epithelial tight junction complex. J Cell Biol 158:967–978PubMedGoogle Scholar
  106. Oldendorf WH, Cornford ME, Brown WJ (1977) The large apparent work capability of the blood–brain barrier: a study of the mitochondrial content of capillary endothelial cells in brain and other tissues of the rat. Ann Neurol 1:409–417PubMedGoogle Scholar
  107. Paemeleire K (2002) The cellular basis of neurovascular metabolic coupling. Acta Neurol Belg 102:153–157PubMedGoogle Scholar
  108. Palant CE, Duffey ME, Mookerjee BK, Ho S, Bentzel CJ (1983) Ca2+ regulation of tight-junction permeability and structure in Necturus gallbladder. Am J Physiol 245:C203–C212PubMedGoogle Scholar
  109. Papadopoulos MC, Saadoun S, Davies DC, Bell BA (2001) Emerging molecular mechanisms of brain tumour oedema. Br J Neurosurg 15:101–108PubMedGoogle Scholar
  110. Pardridge WM (2005) Molecular biology of the blood–brain barrier. Mol Biotechnol 30:57–70PubMedGoogle Scholar
  111. Pedram A, Razandi M, Levin ER (2002) Deciphering vascular endothelial cell growth factor/vascular permeability factor signaling to vascular permeability. Inhibition by atrial natriuretic peptide. J Biol Chem 277:44385–44398PubMedGoogle Scholar
  112. Persidsky Y, Gendelman HE (2003) Mononuclear phagocyte immunity and the neuropathogenesis of HIV-1 infection. J Leukoc Biol 74:691–701PubMedGoogle Scholar
  113. Persidsky Y, Stins M, Way D, Witte MH, Weinand M, Kim KS, Bock P, Gendelman HE, Fiala M (1997) A model for monocyte migration through the blood–brain barrier during HIV-1 encephalitis. J Immunol 158:3499–3510PubMedGoogle Scholar
  114. Persidsky g, Ghorpade A, Rasmussen J, Limoges J, Liu X, Stins M, Fiala M, Way D, Kim K, Witte M, Weinand M, Carchart L, Gendelman H (1999) Microglial and astrocyte chemokines regulate monocyte migration through blood–brain barrier in human immunodeficiency virus-1 encephalitis. Am J Pathol 155:1599–1611PubMedGoogle Scholar
  115. Persidsky Y, Zheng J, Miller D, Gendelman HE (2000) Mononuclear phagocytes mediate blood–brain barrier compromise and neuronal injury during HIV-1-associated dementia. J Leukoc Biol 68:413–422PubMedGoogle Scholar
  116. Pesidsky Y, Heilman D, Haorah J, Zelivyanskay M, Persidsky R, Weber G, Shimokawa H, Kaibuchi K, Ikezu T (2006) Rho-mediated regulation of tight junctions during monocyte migration across blood–brain barrier in HIV-1 encephalitis (HIVE). Blood 107:4720–4730Google Scholar
  117. Petty MA, Wettstein JG (2001) Elements of cerebral microvascular ischaemia. Brain Res Rev 36:23–34PubMedGoogle Scholar
  118. Pratico D (2005) Antioxidants and endothelium protection. Atherosclerosis 181:215–224PubMedGoogle Scholar
  119. Price LS, Langeslag M, ten Klooster JP, Hordijk PL, Jalink K, Collard JG (2003) Calcium signaling regulates translocation and activation of Rac. J Biol Chem 278:39413–39421PubMedGoogle Scholar
  120. Raivich G, Banati R (2004) Brain microglia and blood-derived macrophages: molecular profiles and functional roles in multiple sclerosis and animal models of autoimmune demyelinating disease. Brain Res Rev 46:261–281PubMedGoogle Scholar
  121. Rascher G, Fischmann A, Kroger S, Duffner F, Grote EH, Wolburg H (2002) Extracellular matrix and the blood–brain barrier in glioblastoma multiforme: spatial segregation of tenascin and agrin. Acta Neuropathol (Berl) 104:85–91Google Scholar
  122. Said HM, Ma TY (1994) Mechanism of riboflavine uptake by Caco-2 human intestinal epithelial cells. Am J Physiol 266:G15–G21PubMedGoogle Scholar
  123. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S (1997) Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol 137:1393–1401PubMedGoogle Scholar
  124. Savettieri G, Di Liegro I, Catania C, Licata L, Pitarresi GL, D'Agostino S, Schiera G, De Caro V, Giandalia G, Giannola LI, Cestelli A (2000) Neurons and ECM regulate occludin localization in brain endothelial cells. NeuroReport 11:1081–1084PubMedGoogle Scholar
  125. Schenkel AR, Mamdouh Z, Muller WA (2004) Locomotion of monocytes on endothelium is a critical step during extravasation. Nat Immunol 5:393–400PubMedGoogle Scholar
  126. Schinkel AH, Jonker JW (2003) Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv Drug Deliv Rev 55:3–29PubMedGoogle Scholar
  127. Schinkel AH, Smit JJ, van Tellingen O, Beijnen JH, Wagenaar E, van Deemter L, Mol CA, van der Valk MA, Robanus-Maandag EC, te Riele HP, et al. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood–brain barrier and to increased sensitivity to drugs. Cell 77:491–502PubMedGoogle Scholar
  128. Schmeck B, Brunsch M, Seybold J, Krull M, Eichel-Streiber C, Suttorp N, Hippenstiel S (2003) Rho protein inhibition blocks cyclooxygenase-2 expression by proinflammatory mediators in endothelial cells. Inflammation 27:89–95PubMedGoogle Scholar
  129. Schulze C, Smales C, Rubin LL, Staddon JM (1997) Lysophosphatidic acid increases tight junction permeability in cultured brain endothelial cells. J Neurochem 68:991–1000PubMedCrossRefGoogle Scholar
  130. Shasby DM, Shasby SS (1986) Effects of calcium on transendothelial albumin transfer and electrical resistance. J Appl Physiol 60:71–79PubMedGoogle Scholar
  131. Shaw SK, Bamba PS, Perkins BN, Luscinskas FW (2001) Real-time imaging of vascular endothelial–cadherin during leukocyte transmigration across endothelium. J Immunol 167:2323–2330PubMedGoogle Scholar
  132. Soma T, Chiba H, Kato-Mori Y, Wada T, Yamashita T, Kojima T, Sawada N (2004) Thr(207) of claudin-5 is involved in size-selective loosening of the endothelial barrier by cyclic AMP. Exp Cell Res 300:202–212PubMedGoogle Scholar
  133. Spudich A, Kilic E, Xing H, Kilic U, Rentsch KM, Wunderli-Allenspach H, Bassetti CL, Hermann DM (2006) Inhibition of multidrug resistance transporter-1 facilitates neuroprotective therapies after focal cerebral ischemia. Nat Neurosci 9:487–488PubMedGoogle Scholar
  134. Stamatovic SM, Keep RF, Kunkel SL, Andjelkovic AV (2003) Potential role of MCP-1 in endothelial cell tight junction “opening”: signaling via Rho and Rho kinase. J Cell Sci 116:4615–4628PubMedGoogle Scholar
  135. Stamatovic SM, Shakui P, Keep RF, Moore BB, Kunkel SL, Van Rooijen N, Andjelkovic AV (2005) Monocyte chemoattractant protein-1 regulation of blood–brain barrier permeability. J Cereb Blood Flow Metab 25:593–606PubMedGoogle Scholar
  136. Stamatovic SM, Dimitrijevic OB, Keep RF, Andjelkovic AV (2006) Protein kinase C-α: Rhoa cross talk in CCL2-induced alterations in brain endothelial permeability. J Biol ChemGoogle Scholar
  137. Stevenson BR (1999) Understanding tight junction clinical physiology at the molecular level [comment]. J Clin Invest 104:3–4PubMedCrossRefGoogle Scholar
  138. Strey A, Janning A, Barth H, Gerke V (2002) Endothelial Rho signaling is required for monocyte transendothelial migration. FEBS Lett 517:261–266PubMedGoogle Scholar
  139. Sun ZY, Wei J, Xie L, Shen Y, Liu SZ, Ju GZ, Shi JP, Yu YQ, Zhang X, Xu Q, Hemmings GP (2004) The CLDN5 locus may be involved in the vulnerability to schizophrenia. Eur Psychiatr 19:354–357Google Scholar
  140. Tao-Cheng JH, Brightman MW (1988) Development of membrane interactions between brain endothelial cells and astrocytes in vitro. Int J Dev Neurosci 6:25–37PubMedGoogle Scholar
  141. Tao-Cheng JH, Nagy Z, Brightman MW (1987) Tight junctions of brain endothelium in vitro are enhanced by astroglia. J Neurosci 7:3293–3299PubMedGoogle Scholar
  142. Tilling T, Engelbertz C, Decker S, Korte D, Huwel S, Galla HJ (2002) Expression and adhesive properties of basement membrane proteins in cerebral capillary endothelial cell cultures. Cell Tissue Res 310:19–29PubMedGoogle Scholar
  143. Toneatto S, Finco O, van der Putten H, Abrignani S, Annunziata P (1999) Evidence of blood–brain barrier alteration and activation in HIV-1 gp120 transgenic mice. AIDS 13:2343–2348PubMedGoogle Scholar
  144. Tong XK, Hamel E (1999) Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease. Neuroscience 92:163–175PubMedGoogle Scholar
  145. Tontsch U, Bauer H (1991) Glial cells and neurons induce blood–brain barrier enzymes in cerebral endothelial cells. Brain Res 539:247–253PubMedGoogle Scholar
  146. Traweger A, Fuchs R, Krizbai IA, Weiger TM, Bauer HC, Bauer H (2003) The tight junction protein ZO-2 localizes to the nucleus and interacts with the heterogeneous nuclear ribonucleoprotein scaffold attachment factor-B. J Biol Chem 278:2692–2700PubMedGoogle Scholar
  147. Tsukamoto T, Nigam SK (1999) Role of tyrosine phosphorylation in the reassembly of occludin and other tight junction proteins. Am J Physiol 276:F737–F750PubMedGoogle Scholar
  148. Umeda K, Matsui T, Nakayama M, Furuse K, Sasaki H, Furuse M, Tsukita S (2004) Establishment and characterization of cultured epithelial cells lacking expression of ZO-1. J Biol Chem 279:44785–44794PubMedGoogle Scholar
  149. van Bruggen N, Thibodeaux H, Palmer JT, Lee WP, Fu L, Cairns B, Tumas D, Gerlai R, Williams SP, van Lookeren Campagne M, Ferrara N (1999) VEGF antagonism reduces edema formation and tissue damage after ischemia/reperfusion injury in the mouse brain. J Clin Invest 104:1613–1620PubMedGoogle Scholar
  150. van Buul JD, Hordijk PL (2004) Signaling in leukocyte transendothelial migration. Arterioscler Thromb Vasc Biol 24:824–833PubMedGoogle Scholar
  151. van Wetering S, van Buul JD, Quik S, Mul FP, Anthony EC, ten Klooster JP, Collard JG, Hordijk PL (2002) Reactive oxygen species mediate Rac-induced loss of cell–cell adhesion in primary human endothelial cells. J Cell Sci 115:1837–1846PubMedGoogle Scholar
  152. Vaucher E, Tong XK, Cholet N, Lantin S, Hamel E (2000) GABA neurons provide a rich input to microvessels but not nitric oxide neurons in the rat cerebral cortex: a means for direct regulation of local cerebral blood flow. J Comp Neurol 421:161–171PubMedGoogle Scholar
  153. Volk H, Potschka H, Loscher W (2005) Immunohistochemical localization of P-glycoprotein in rat brain and detection of its increased expression by seizures are sensitive to fixation and staining variables. J Histochem Cytochem 53:517–531PubMedGoogle Scholar
  154. Vorbrodt AW, Dobrogowska DH (2003) Molecular anatomy of intercellular junctions in brain endothelial and epithelial barriers: electron microscopist's view. Brain Res Rev 42:221–242PubMedGoogle Scholar
  155. Wachtel M, Frei K, Ehler E, Fontana A, Winterhalter K, Gloor SM (1999) Occludin proteolysis and increased permeability in endothelial cells through tyrosine phosphatase inhibition. J Cell Sci 112:4347–4356PubMedGoogle Scholar
  156. Williams KC, Corey S, Westmoreland SV, Pauley D, Knight H, deBakker C, Alvarez X, Lackner AA (2001) Perivascular macrophages are the primary cell type productively infected by simian immunodeficiency virus in the brains of macaques: implications for the neuropathogenesis of AIDS. J Exp Med 193:905–915PubMedGoogle Scholar
  157. Willis CL, Leach L, Clarke GJ, Nolan CC, Ray DE (2004a) Reversible disruption of tight junction complexes in the rat blood–brain barrier, following transitory focal astrocyte loss. Glia 48:1–13PubMedGoogle Scholar
  158. Willis CL, Nolan CC, Reith SN, Lister T, Prior MJ, Guerin CJ, Mavroudis G, Ray DE (2004b) Focal astrocyte loss is followed by microvascular damage, with subsequent repair of the blood–brain barrier in the apparent absence of direct astrocytic contact. Glia 45:325–337PubMedGoogle Scholar
  159. Witt KA, Mark KS, Huber J, Davis TP (2005) Hypoxia-inducible factor and nuclear factor kappa-B activation in blood–brain barrier endothelium under hypoxic/reoxygenation stress. J Neurochem 92:203–214PubMedGoogle Scholar
  160. Wittchen ES, van Buul JD, Burridge K, Worthylake RA (2005a) Trading spaces: Rap, Rac, and Rho as architects of transendothelial migration. Curr Opin Hematol 12:14–21PubMedGoogle Scholar
  161. Wittchen ES, Worthylake RA, Kelly P, Casey PJ, Quilliam LA, Burridge K (2005b) Rap1 GTPase inhibits leukocyte transmigration by promoting endothelial barrier function. J Biol Chem 280:11675–11682PubMedGoogle Scholar
  162. Wojciak-Stothard B, Williams L, Ridley AJ (1999) Monocyte adhesion and spreading on human endothelial cells is dependent on Rho-regulated receptor clustering. J Cell Biol 145:1293–1307PubMedGoogle Scholar
  163. Wolburg H, Lippoldt A (2002) Tight junctions of the blood–brain barrier: development, composition and regulation. Vascul Pharmacol 38:323–337PubMedGoogle Scholar
  164. Wong V (1997) Phosphorylation of occludin correlates with occludin localization and function at the tight junction. Am J Physiol 273:C1859–C1867PubMedGoogle Scholar
  165. Wong V, Gumbiner BM (1997) A synthetic peptide corresponding to the extracellular domain of occludin perturbs the tight junction permeability barrier. J Cell Biol 136:399–409PubMedGoogle Scholar
  166. Xu H, Dawson R, Crane IJ, Liversidge J (2005) Leukocyte diapedesis in vivo induces transient loss of tight junction protein at the blood–retina barrier. Invest Ophthalmol Vis Sci 46:2487–2494PubMedGoogle Scholar
  167. Yamamoto T, Harada N, Kawano Y, Taya S, Kaibuchi K (1999) In vivo interaction of AF-6 with activated Ras and ZO-1. Biochem Biophys Res Commun 259:103–107PubMedGoogle Scholar
  168. Yang L, Froio RM, Sciuto TE, Dvorak AM, Alon R, Luscinskas FW (2005) ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-α-activated vascular endothelium under flow. Blood 106:584–592PubMedGoogle Scholar
  169. Ye J, Tsukamoto T, Sun A, Nigam SK (1999) A role for intracellular calcium in tight junction reassembly after ATP depletion–repletion. Am J Physiol 277:F524–F532PubMedGoogle Scholar
  170. Zhang W, Mojsilovic-Petrovic J, Andrade MF, Zhang H, Ball M, Stanimirovic DB (2003) The expression and functional characterization of ABCG2 in brain endothelial cells and vessels. FASEB J 17:2085–2087PubMedGoogle Scholar
  171. Zlokovic BV (2002) Vascular disorder in Alzheimer's disease: role in pathogenesis of dementia and therapeutic targets. Adv Drug Deliv Rev 54:1553–1559PubMedGoogle Scholar
  172. Zlokovic BV (2005) Neurovascular mechanisms of Alzheimer's neurodegeneration. Trends Neurosci 28:202–208PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, Inc. 2006

Authors and Affiliations

  • Yuri Persidsky
    • 1
    • 2
    • 3
  • Servio H. Ramirez
    • 1
    • 2
  • James Haorah
    • 1
    • 2
  • Georgette D. Kanmogne
    • 1
    • 2
  1. 1.Center for Neurovirology and Neurodegenerative DisordersUniversity of Nebraska Medical CenterOmahaUSA
  2. 2.Department of Pharmacology and Experimental NeuroscienceUniversity of Nebraska Medical CenterOmahaUSA
  3. 3.Department of Pathology and Microbiology, 985215University of Nebraska Medical CenterOmahaUSA

Personalised recommendations